Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study

1. Sastre, J.
2. Aranda, E.
3. Massutí, B.
4. Tabernero, J.
5. Chaves, M.
6. Abad, A.
7. Carrato, A.
8. Reina, J.J.
9. Queralt, B.
10. Gómez-España, A.
11. González-Flores, E.
12. Rivera, F.
13. Losa, F.
14. García, T.
15. Sanchez-Rovira, P.
16. Maestu, I.
17. Díaz-Rubio, E.